GRDNGuardian Pharmacy Services, Inc.
Is the price fair?
In line with its sector. That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.
Sector median 25.1× across 135 covered peers. EV/EBIT counts debt as part of the price, so a cash-rich and a borrowed company can be compared on the same footing.
Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.
What GRDN's price assumes
Guardian Pharmacy Services, Inc. has no trailing P/E on file, so the price is measured against sales instead: 1.71× revenue.
Price / sales · no trailing P/E on file: measured against sales instead
- Price / book
- 9.69
Price / book · today's price, trailing year to Jun 30, 2026
- EV / sales
- 1.66
EV / sales
Details›
- Price / booktoday's price, trailing year to Jun 30, 2026
- 9.69
- EV / EBITtoday's price, trailing year to Jun 30, 2026
- 28.4
- EV / salestoday's price, trailing year to Jun 30, 2026
- 1.66
- Market capitalisation63.3 million shares, counted Aug 3, 2026
- $2.50B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Medical Care Facilities
The closest names by size in the same industry